New patient studies surrounding the medication Retatrutide , specifically the high-dose formulation ZPHC ZPHC, indicate a impressive effect on body mass loss and related health conditions . Experts posit that this dual acting , targeting both GLP-1 and GIP receptors , has the potential to repres